from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3282/-

LFCtreatmentdescriptionclass of inhibitor

-1.077

Amikacinug/mL Amikacintranslation

-1.125

Cap5-10ug/mL Capreomycintranslation

-1.575

Rox10-50 ug/mL Roxithromycintranslation

0.291

SM2-5 ug/mL Streptomycintranslation

-0.436

Tet5-10 ug/mL Tetracyclinetranslation

0.448

Rif0.2-5ug/mL Rifampicintranscription

-0.348

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.551

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.977

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.146

CPZ10-50 ug/mL Chlorpromazinerespiration

0.610

Clofazimine10-13 ug/mL Clofaziminerespiration

0.734

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.887

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.124

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.542

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.437

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.780

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.851

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.684

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.565

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.036

KCN5-20 ug/mL Potassium cyaniderespiration

0.672

NaN30.2-2 mM Sodium aziderespiration

0.529

Nigericin50 uM Nigericinrespiration

-0.616

TRC10-150 ug/mL Triclosanrespiration

-0.944

TRZ10-25 ug/mL Thioridazinerespiration

-1.859

Valinomycin0.5-10 uM Valinomycinrespiration

1.416

ZnSO42 mM ZnSO4respiration

-0.255

menadione6-10 ug/mL Menadionerespiration

-0.018

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.476

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.172

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.070

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.004

NRP_1Non-replicating persistence stage 1dosRassociated

0.986

Amp0.2mg/mL AmpicillincellWall

0.404

Cephalexin20-100 ug/mL CephalexincellWall

0.251

Cerulenin0.32-5 ug/mL CerulenincellWall

0.793

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.969

EMB10-20 ug/mL EthambutolcellWall

1.171

Eta12-40 ug/mL EthionamidecellWall

-0.014

INH0.2-0.4 ug/mL IsoniazidcellWall

0.274

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.007

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.356

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.848

BZA0.12 mg/mL BenzamidearomaticAmides

-0.147

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.532

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.376

H2O24 mM hydrogen peroxideDNAdamaging

-0.158

Levo10 ug/mL LevofloxacinDNAdamaging

0.469

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.461

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.012

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.436

UVUV-irradiationDNAdamaging

-0.741

ARP41-4 ug/mL Antitubercular compound ARP4?

0.162

Antimycin12.5-50 ug/mL Antimycin A?

0.809

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.264

PA_110-50 ug/mL Antitubercular compound PA-1?

0.288

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.027

PA8240.2-2 ug/mL PA-824?

-0.133

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.307

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.334

Verapamil50 uM Verapamil?

0.572

mercaptoethanol2 mM 2-Mercaptoethanol?

0.549

methoxatin10-20 ug/mL Methoxatin?